Dosimetric Comparison of Volumetric Arc Therapy and Helical Tomotherapy in Locally Advanced Non-Small Cell Lung Cancer
Open Access
- 30 September 2025
- journal article
- Published by Turkish Medical Physics Association in Advances in Medical Pyhsics and Applied Sciences
- Vol. 1 (3) , 91-96
Abstract
Radiotherapy (RT) in lung cancer emphasizes the use of modern techniques due to the size of the treatment area and doses to critical organs. This study aimed to evaluate dosimetric differences between Helical Tomotherapy (HT) and Volumetric Arc Radiotherapy (VMAT) plans and which technique is more appropriate in patients with stage IIIB inoperable non-small cell lung cancer (NSCLC). Fifteen patients with stage IIIB inoperable NSCLC and a planning target volume (PTV) >200 cc or length >10 cm, treated between January 2024 and December 2024, were included. A prescription of 60 Gy in 30 fractions was applied. Plans were evaluated using conformity index (CI), homogeneity index (HI), and doses to critical organs. The median PTV volume was 385 cc (range: 213–615 cc). Both planning techniques covered 98% of the prescribed dose (p = 0.887), but HT demonstrated significantly better HI (p = 0.011). HT also yielded significantly lower doses in total lung V5, contralateral lung V5, heart mean dose, heart V50, and spinal cord max dose. Esophageal doses showed no significant differences. Although dose constraints for the esophagus were met in both planning systems, a lower dose was achieved with HT." Modern planning systems can achieve desired doses in large volume targets while remaining within dose limits for organs at risk. HT provided significant advantages in critical organ sparing and better homogeneity in dose distribution. The selection of the appropriate technique should be determined based on the characteristics of the tumor and the specific needs of the patient.Keywords
This publication has 15 references indexed in Scilit:
- Comparison of Radiation Pneumonitis in Lung Cancer Patients Treated with HT versus IMRT and Circulating Lymphocyte Subsets as Predicting Risk FactorsJournal of Inflammation Research, 2021
- Dosimetric evaluation of helical tomotherapy and volumetric-modulated arc therapy for malignant pleural mesothelioma: a planning study for dose escalationTranslational Cancer Research, 2021
- Dosimetric comparison of helical tomotherapy and hybrid (3DCRT-VMAT) technique for locally advanced non-small cell lung cancerJournal of Radiotherapy in Practice, 2020
- Dosimetric comparison of the helical tomotherapy, volumetric-modulated arc therapy and fixed-field intensity-modulated radiotherapy for stage IIB-IIIB non-small cell lung cancerScientific Reports, 2017
- Cardiac Toxicity After Radiotherapy for Stage III Non–Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 GyJournal of Clinical Oncology, 2017
- Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical TrialJournal of Clinical Oncology, 2017
- Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410JNCI: Journal of the National Cancer Institute, 2011
- Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLCRadiotherapy and Oncology, 2008
- Volumetric modulated arc therapy: IMRT in a single gantry arcMedical Physics, 2007
- Radiation therapy oncology group: Radiosurgery quality assurance guidelinesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993